skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Therapeutic Hepatitis C Immune Globulin (Code C105618)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Therapeutic Hepatitis C Immune Globulin

Definition: A human plasma-derived, polyclonal, intravenous immunoglobulin G (IgG) formulation containing high levels of antibodies against hepatitis C virus (HCV), a small, enveloped, single-stranded RNA virus belonging to the Flaviviridae family, with potential immunomodulating and antiviral activities. The hepatitis C IgG is isolated from donors expressing high amounts of HCV antibodies. Upon intravenous administration, the anti-HCV antibodies bind to the virus and provide passive immunization against HCV. This may prevent both infection by HCV in immunocompromised patients and hepatitis C-related liver disease. The polyclonal anti-HCV antibodies are able to target various viral epitopes.

Label: Therapeutic Hepatitis C Immune Globulin

NCI Thesaurus Code: C105618 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1689829  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Anti-HCV Immunoglobulin
Therapeutic Hepatitis C Immune Globulin

External Source Codes: 
PDQ Closed Trial Search ID 747593
PDQ Open Trial Search ID 747593 (check for NCI PDQ open clinical trial info)
UMLS CUI C1689829

Other Properties:
     Name Value (qualifiers indented underneath)
code C105618
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom